The reported failure "delta p increased due to clotting" occurred during use and the hls set was replaced.Investigation results: trend search.Dhr review.Ra review.The received product was investigated in mcp's laboratory on 2021-01-22 with the following outcome: a visual inspection was performed.No clotting detected.A tightness test according lv 201 und lv 202 was performed.No pressure drop could be detected.No leakage on the hls module noticed.Conclusion: no blood coagulation was found during the visual inspection and during the cleaning of the product.No leaks were found on the complaint sample during the leak test.In the subsequent function test of the centrifugal pump with liquid, all test speeds were successfully set and a flow of the test medium was thus established.When running dry, the pump only showed an imbalance at an increased speed of 3500 rpm.This can be traced back to the type of bearing (plain bearing) of the rotor and will not be pursued further, since the rotor showed no imbalance at the reference rotation of 150 rpm.This rules out any general inoperability of the product and the complaint could not be confirmed.It was not possible to determine a possible cause of a product related malfunction.According to the risk assessment (hls set advanced 5.0 / hls set advanced 7.0, dms # (b)(4), v26) following causes could lead to coagulation: de-airing luer lock connection too loose.Air remains in or enters the circuit.Hemostasis.Air or blood remains in luer lock access port.Too low anticoagulation.Too low at level, effect of heparin is too limited.Protamine sulfate enters the hls set.Administration of substitution of congealable substance such as plateles.Consumption) coagulopathy.Thrombozytopenia.Device history record (dhr) review was performed and there were no references found, which are indicating a nonconformance of the product in question.The reported failure "delta p increased due to clotting" occurred during use and could not be confirmed.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonary¿s trending program and additional investigations or corrections will be implemented in case of adverse.
|